|
|
|
|
|
||
|
|||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | |||||
Research Article |
1 Department of Cell Biology and Genetics, Erasmus University, Rotterdam,
Netherlands
2 Centre for Genome Research, University of Edinburgh, Edinburgh, UK
3 Department of Hematology, Erasmus University, Rotterdam, Netherlands
4 Amgen, Thousand Oaks, CA, USA
* These authors contributed equally to this work
Author for correspondence (e-mail:
dzierzak{at}ch1.fgg.eur.nl
)
Accepted 12 March 2002
Throughout life, the hematopoietic system requires a supportive microenvironment that allows for the maintenance and differentiation of hematopoietic stem cells (HSC). To understand the cellular interactions and molecules that provide these functions, investigators have previously established stromal cell lines from the late gestational stage and adult murine hematopoietic microenvironments. However, the stromal cell microenvironment that supports the emergence, expansion and maintenance of HSCs during mid-gestational stages has been largely unexplored. Since several tissues within the mouse embryo are known to harbor HSCs (i.e. aortagonads-mesonephros, yolk sac, liver), we generated numerous stromal cell clones from these mid-gestational sites. Owing to the limited cell numbers, isolations were performed with tissues from transgenic embryos containing the ts SV40 Tag gene (tsA58) under the transcriptional control of constitutive and ubiquitously expressing promoters. We report here that the growth and cloning efficiency of embryonic cells (with the exception of the aorta) is increased in the presence of the tsA58 transgene. Furthermore, our results show that the large panel of stromal clones isolated from the different embryonal subregions exhibit heterogeneity in their ability to promote murine and human hematopoietic differentiation. Despite our findings of heterogeneity in hematopoietic growth factor gene expression profiles, high-level expression of some factors may influence hematopoietic differentiation. Interestingly, a few of these stromal clones express a recently described chordin-like protein, which is an inhibitor of bone morphogenic proteins and is preferentially expressed in cells of the mesenchymal lineage.
Key words: Stroma, Hematopoiesis, AGM, Development, tsA58 transgene
This article has been cited by other articles:
|
|
 |
|
  C. Durand, C. Robin, K. Bollerot, M. H. Baron, K. Ottersbach, and E. Dzierzak Embryonic stromal clones reveal developmental regulators of definitive hematopoietic stem cells PNAS, December 26, 2007; 104(52): 20838 - 20843. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. A.J. Oostendorp, C. Robin, C. Steinhoff, S. Marz, R. Brauer, U. A. Nuber, E. A. Dzierzak, and C. Peschel Long-Term Maintenance of Hematopoietic Stem Cells Does Not Require Contact with Embryo-Derived Stromal Cells in Cocultures Stem Cells, June 1, 2005; 23(6): 842 - 851. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. C. Mendes, C. Robin, and E. Dzierzak Mesenchymal progenitor cells localize within hematopoietic sites throughout ontogeny Development, March 1, 2005; 132(5): 1127 - 1136. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Harvey and E. Dzierzak Cell-Cell Contact and Anatomical Compatibility in Stromal Cell-Mediated HSC Support During Development Stem Cells, May 1, 2004; 22(3): 253 - 258. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Nakayama, C.-y. E. Han, L. Cam, J. I. Lee, J. Pretorius, S. Fisher, R. Rosenfeld, S. Scully, R. Nishinakamura, D. Duryea, et al. A novel chordin-like BMP inhibitor, CHL2, expressed preferentially in chondrocytes of developing cartilage and osteoarthritic joint cartilage Development, January 1, 2004; 131(1): 229 - 240. [Abstract] [Full Text] [PDF]
|
|
